Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study

BACKGROUND: Desensitization with IVIG and rituximab allows acceptable graft survival in sensitized kidney transplant recipients with preexisting donor-specific antibodies (DSAs) and a positive crossmatch. There is little published data reporting the durability of DSA removal in kidney transplant rec...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Transplant Direct
Prif Awduron: Shaffer, David, Feurer, Irene D., Crowe, Deborah, Schaefer, Heidi
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Lippincott Williams & Wilkins 2016
Pynciau:
Kidney Transplantation
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946491/
https://ncbi.nlm.nih.gov/pubmed/27500255
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000570
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg